Tag - Hodgkin’s lymphoma

Feature

3DS Telo-HL test aims to personalize cancer treatment

By Len Zehrs 3D Signatures (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) has reported positive results from a preliminary analysis of trial data for Telo-HL, its test for Hodgkin’s lymphoma (HL) that is designed to personalize...

February 20, 2018

Feature

3D Signatures seeking partners for genomic imaging platform

By Len Zehr 3D Signatures (TSX-V:DXD) which has developed proprietary software with the potential to analyze a patient’s chromosomal arrangement, or signature, is seeking collaborations to advance its TeloView platform...

November 29, 2016

Tag - Hodgkin’s lymphoma

3DS Telo-HL test aims to personalize cancer treatment

3D Signatures seeking partners for genomic imaging platform

General

More